Lower prices for 15 high-cost drugs

The Centers for Medicare & Medicaid Services (CMS) announced that 15 high-cost drugs used by millions of Medicare beneficiaries will get Medicare price cuts in 2027. Seniors are expected to receive an estimated $685 million in out-of-pocket relief, benefiting the approximately 5.3 million Medicare beneficiaries who take these 15 medications. Kathryn Pomroy, writing for Kiplinger, reports on the effect of the price negotiation. Read Ms. Pomroy’s article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.